Introduction of molecular point-of-care testing for SARS-CoV-2 in a triage unit of a large maternity hospital: An evaluation of staff experiences - 12/03/25
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Highlights |
• | SARS-CoV-2 point-of-care (POC) test was implemented in a busy maternity hospital with limited isolation capacity, during the COVID-19 pandemic. |
• | The mean Turnaround Time (TAT) for the POC platform was 5.3x quicker when compared with local laboratory PCR testing. |
• | Samples sent for laboratory testing reduced by almost one third, following introduction of the POC device. |
• | Staff satisfaction survey indicated ease of use and benefits for diagnosis and patient management. |
• | POC testing decreased laboratory testing volume and TAT for symptomatic women. |
Abstract |
Context |
Recent advances in the development of rapid SARS-CoV-2 point of care (POC) testing provided an opportunity to aid clinical decision making in front-line healthcare settings. Perspectives of POC COVID-19 screening of pregnant women are under-researched.
Objective |
To assess the impact of a SARS-CoV-2 POC testing platform implemented in a busy maternity hospital, with limited isolation capacity, during the third wave of the COVID-19 pandemic.
Methods |
We conducted a before and after comparison of two consecutive 12-month periods and a retrospective evaluation of staff attitudes and POC test acceptance. Turnaround Time (TAT) and testing numbers were assessed by computer audit. Qualitative data was collected using confidential questionnaires.
Results |
Mean TAT for the POC platform was 5.3x quicker (p < 0.001, chi-square test) when compared with local virus laboratory PCR testing. Samples sent for laboratory testing reduced by almost one third, following introduction of the POC device. A total of 27 staff members completed a POC testing satisfaction survey, which documented ease of use and benefits for diagnosis assistance, patient management and patient experience.
Conclusion.
In this single-center maternity setting, POC testing decreased laboratory testing volume and SARS-Cov-2 result TAT for symptomatic women and those awaiting crucial investigations. POC COVID-19 investigation was deemed acceptable by the clinical team for facilitating patient placement, management, and use of limited isolation capacity.
Le texte complet de cet article est disponible en PDF.Keywords : Maternity hospital, SARS-CoV-2, Point of care testing, COVID-19
Plan
Vol 55 - N° 2
Article 105024- mars 2025 Retour au numéro
Article précédent
- Update of guidelines for management of community acquired pneumonia in adults by the French infectious disease society (SPILF) and the French-speaking society of respiratory diseases (SPLF). Endorsed by the French intensive care society (SRLF), the French microbiology society (SFM), the French radiology society (SFR) and the French emergency society (SFMU)
- Aurélien Dinh, François Barbier, Jean-Pierre Bedos, Mathieu Blot, Vincent Cattoir, Yann-Erick Claessens, Xavier Duval, Pierre Fillâtre, Maxime Gautier, Yann Guegan, Sophie Jarraud, Alban Le Monnier, David Lebeaux, Paul Loubet, Constance de Margerie, Philippe Serayet, Yacine Tandjaoui-Lambotte, Emmanuelle Varon, Yves Welker, Damien Basille
- Delta and Omicron SARS-CoV-2 pneumonia: Comparison of clinical and radiological features
- Jonathan Pehlivan, Pierre Berge, Anne-Laurence Gourdier, Michael Phelippeau, Pierre Danneels, Rafael Mahieu, Vincent Dubée
Bienvenue sur EM-consulte, la référence des professionnels de santé.